Heller-Rouassant S

Idioma: Español
Referencias bibliográficas: 7
Paginas: 156
Archivo PDF: 44.91 Kb.

FRAGMENTO

Objetivo: determinar el efecto del omeprazol en la acidez gástrica y reflujo gastroesofágico ácido en niños pretérmino con reflujo ácido patológico determinado por pHmetría esofágica de 24 horas.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Omari TI, Haslam RR, Lundborg P, Davidson GP. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux. J Pediatr Gastroenterol Nutr 2007; 44: 41-4.

2. Hassall E, Israel D, Shepherd R, et al. Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy, safety, tolerability and dose requirements. International Pediatric Omeprazole Study Group. J Pediatr 2000; 137: 800-7.

3. Gibbons TE, Gold BD. The use of proton pump inhibitors in children: a comprehensive review. Pediatr Drugs 2003; 5: 25-40.

4. Litalien C, Theoret Y, Faure C. Pharmacokinetics of proton pump inhibitors in children. Clin Pharmacokinet 2005; 44: 441-66.

5. Hoyo-Vadillo C, Venturelli CR, Gonzalez H, et al. Metabolism of omeprazole after two oral doses in children 1 to 9 months old. Proc West Pharmacol Soc 2005; 48: 108-9.

6. Kearns GL, Winter HS. Proton pump inhibitors in pediatrics: relevant pharmacokinetics and pharmacodynamics. J Pediatr Gastroenterol Nutr 2003; 37 (Suppl. 1): S52-9.

7. Kolos P. Excessively high doses of omeprazole being used in infants. J Peditr Child Health 2006; 42: 747-7.